Iain Cockburn
Richard C. Shipley Professor in Strategy & Innovation
Education
PhD, Harvard University, 1990
MA, Harvard University , 1987
BS, Queen Mary College University of London, 1984
Selected Research Presentations
Cockburn, I. Interoperability in Light of the Oracle v. Google case, TPRI Interoperability Workshop, 2022
Cockburn, I. The Geography of AI, 5th RIE (Conference of the Network of Innovation and Entrepreneurship Economics in Latin America and the Caribbean) and 12th Conference on Model-based Evidence on Innovation and Development (MEIDE), online, United Nations University – MERIT, 2021
Cockburn, I. , Hunt, J. , Bessen, J. Is distance from innovation a barrier to the adoption of artificial intelligence?, NBER Conference on Economics of Artificial Intelligence, University of Toronto, 2021
Cockburn, I. The role of TRIPS in encouraging technology diffusion, World Trade Organization Webinar on Dissemination of Health Technologies, online, 2021
Publications
Macgarvie, M., Cockburn, I., McKeon, J. (2023). “Canada’s Patent Productivity Paradox: Recent Trends and Implications for Future Growth”, International Productivity Monitor, 45 (Fall), 120-154
Cockburn, I., Henderson, R., Stern, S. (2019). The Impact of Artificial Intelligence on Innovation: An Exploratory Analysis. In Ajay, Agrawal., Joshua, Gans., Avi, Goldfarb. (Eds.), “The Economics of Artificial Intelligence: An Agenda”, University of Chicago Press
Cockburn, I., Lanjouw, J., Schankerman, M. (2016). “Patents and the Global Diffusion of New Drugs.”, Am Econ Rev, 106 (1), 136-164
Agrawal, A., Cockburn, I., Zhang, L. (2015). “Deals not done: Sources of failure in the market for ideas”, Strategic Management Journal, 36 (7), 976-986
Freedman, L., Cockburn, I., Simcoe, T. (2015). “The Economics of Reproducibility in Preclinical Research”, PLoS Biology, 13 (6)
Berndt, E., Cockburn, I. (2014). “Price Indexes for Clinical Trial Research: A Feasibility Study”, Monthly Labor Review
Agrawal, A., Cockburn, I., Galasso, A., Oettl, A. (2014). “Why are some regions more innovative than others? The role of small firms in the presence of large labs”, Journal of Urban Economics, 81 149-165
Mueller, E., Cockburn, I., MacGarvie, M. (2013). “Access to intellectual property for innovation: Evidence on problems and coping strategies from German firms”, Research Policy, 42 (2), 529-541
Kleis, L., Chwelos, P., Ramirez, R., Cockburn, I. (2012). “Information Technology and Intangible Output: The Impact of IT Investment on Innovation Productivity”, Information Systems Research, 23 (1), 42-59
Berndt, E., Blalock, N., Cockburn, I. (2011). “Diffusion of New Drugs in the Post-TRIPS Era”, International Journal of the Economics of Business, 18 (2), 203-224
Cockburn, I., MacGarvie, M. (2011). “Entry and Patenting in the Software Industry”, Management Science, 57 (5), 915-933
Bollyky, T., Cockburn, I., Berndt, E. (2010). “Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases”, Clinical Trials, 7 (6), 719-734
Cockburn, I., MacGarvie, M., Mueller, E. (2010). “Patent thickets, licensing and innovative performance”, Industrial and Corporate Change, 19 (3), 899-925
Wagner, S., Cockburn, I. (2010). “Patents and the survival of Internet-related IPOs”, Research Policy, 39 (2), 214-228
Cockburn, I., Stern, S. (2010). “Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy”, Capitalism and Society, 5 (1)
Agrawal, A., Cockburn, I., Rosell, C. (2010). “Not Invented Here? Innovation in company towns”, Journal of Urban Economics, 67 (1), 78-89
Cockburn, I., Slaughter, M. (2010). “The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions”, Innovation Policy and the Economy, 10 129-157
Cockburn, I., MacGarvie, M. (2009). “Patents, Thickets and the Financing of Early-Stage Firms: Evidence from the Software Industry”, Journal of Economics and Management Strategy, 18 (3), 729-773
Cockburn, I. (2009). “US/Canadian Licensing in 2007/2008: Survey Results”, les Nouvelles: Journal of the Licensing Executives Society, XLIV (1)
(2008). Innovation in Global Industries.”Innovation in Global Industries”, National Academies Press
Chwelos, P., Berndt, E., Cockburn, I. (2008). “Faster, smaller, cheaper: an hedonic price analysis of PDAs”, Applied Economics, 40 (22), 2839-2856
Grabowski, H., Cockburn, I., Long, G. (2006). “The market for follow-on biologics: How will it evolve?”, Health Affairs, 25 (5), 1291-1301
Cockburn, I. (2006). “Is the pharmaceutical industry in a productivity crisis?”, Innovation Policy and the Economy 7, 7 1-32
Cockburn, I., Henderson, R., Stern, S. (2000). “Untangling the origins of competitive advantage”, Strategic Management Journal, 21 (10-11), 1123-1145
Berndt, E., Cockburn, I., Cocks, D., Epstein, A., Griliches, Z. (1998). “Prescription drug prices for the elderly”, Monthly Labor Review, 121 (9), 23-34
Henderson, R., Cockburn, I. (1994). “Measuring Competence: Exploring Firm Effects in Pharmaceutical Research”, Strategic Management Journal, 15 63-84
Griliches, Z., Cockburn, I. (1994). “Generics and New Goods in Pharmaceutical Price Indexes”, American Economic Review, 84 (5), 1213-1232
Cockburn, I., Griliches, Z. (1988). “Industry Effects and Appropriability Measures in the Stock Market’s Valuation of R&D and Patents”, American Economic Review, 78 (2), 419-423